Semarion, a University ofCambridge spin-out from the Cavendish Laboratory, has raised $3.8 million (£2.9million) in funding to support the expansion of its cell-based screeningtechnology. The round wa…
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired, R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal…
Berlin-founded biotech startup Cellbricks Therapeutics has raised €10 million to advance its goal of 3D-printed organs, beginning with biofabricated human tissue implants. If successful, Cellbricks i…
Biotech startup NanoZymeX has obtained €160,000 (CHF 150,000) from Venture Kick to advance a new platform for enzyme replacement therapy using lipid nanoparticles. Spun out of research at the Univers…
Rivia, the Zurich-based data engine for clinical trial intelligence, today announced a $15 million Series A led by Earlybird, with participation from Defiant and existing investors Speedinvest, Amino …
Living Models, a Paris–Berkeleystartup, has raised $7 million in seed funding as it emerges from stealth todevelop foundation models for biology trained on DNA, RNA, and multi-omics dataaimed at impro…
Cytotrait, aspinout from The University of Manchester focused on developing new traits forfood and agricultural applications, has closed a £3 million seed funding round.The round was led by Northern G…
University of Edinburgh spin-out BIOCAPTIVA has raised £1.58 million in a new funding round and launched its first product in the US. BIOCAPTIVA’s novel magnetic bead technology is designed to solve o…
Wilbe, the venture fund and platform that trains and backs scientists to build companies from day one, today announces the launch of its first dedicated lab facility in White City, London.To date, Wil…
London-basedbiomaterials company Shellworks has raised $15 million in a Series A fundinground led by Paris-based impact investment fund alter equity. The round alsoincluded participation from Nat Frie…